Pharmacovigilance – News and Features

Increased rates of stillborn births were seen among people who lived near areas where pesticides were used during their first trimester of pregnancy or pre-conception.

Scientists have taken a fresh approach to finding a way to target neuroblastoma, the most common solid tumor of infancy. Their novel gene target could offer hope for finding alternative treatments with fewer long-term side effects.

Researchers have found evidence of higher levels of the plastic chemical bisphenol A (BPA) in pregnant mothers who gave birth to sons with autism.

Until now, the mechanisms of COVID-19 diarrhea were not understood, and this research creates a more complete picture of the mechanisms that could lead to potential treatments.

Neuron-tagging method developed by researchers at UC Davis reveals how psychedelic compounds impact individual neurons in the brain.

This article tells the story of Victoria Gray, the first patient to receive a CRISPR cell-based gene therapy for sickle cell disease (SCD). We explore the struggles of SCD, the mistreatment of minorities in medical settings and the implications of gene therapy accessibility.

Researchers at the University of Helsinki and HUS Helsinki University Hospital succeeded in creating cells whose proliferation can be controlled. The technique enables new and safe cell therapies.

A new technique to help CAR T-cells persist longer in the body and form a memory of the cancer cell could prevent cancer recurrence.

Regular aspirin may help lower the risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a new study.

For the first time, researchers have now succeeded in mapping the interactions of 144 active substances with around 8,000 proteins. The results could help to identify previously unknown potential benefits of existing drugs.